You are using an outdated browser. Please upgrade your browser to improve your experience.
hyperparathyroidism
Disease Summary
Associated Targets (25)
Tbio
13
Tclin
6
Tchem
6
Mondo Description Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.
Disease Ontology Description A parathyroid gland disease characterized by an overactivity of the parathyroid glands, leading to an excess of parathyroid hormone in the body.
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
Description from Disease Ontology
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
COHD:133729
DOID:13543
EFO:0008506
ICD9:252.0
ICD9:252.00
MESH:D006961
NCIT:C48259
SCTID:66999008
UMLS:C0020502
MONDO:0001741
High level summary of knowledge for a disease, including descriptions and datasource references.